{"id":48521,"date":"2018-03-09T17:08:12","date_gmt":"2018-03-09T17:08:12","guid":{"rendered":"https:\/\/mppt.hu\/project\/2018-marcius-xx-evfolyam-1-szam\/"},"modified":"2020-10-19T19:57:36","modified_gmt":"2020-10-19T19:57:36","slug":"2018-marcius-xx-evfolyam-1-szam","status":"publish","type":"project","link":"https:\/\/mppt.hu\/en\/project\/2018-marcius-xx-evfolyam-1-szam\/","title":{"rendered":"Volume 20, Issue 1, March 2018"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;3.22&#8243; custom_padding=&#8221;28px|0px|0|0px|false|false&#8221;][et_pb_row _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;27px|0px|0|0px|false|false&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;3.27.4&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#000000&#8243; header_4_font=&#8221;|700||on|||||&#8221; header_4_text_align=&#8221;center&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_font_size=&#8221;19px&#8221; header_4_letter_spacing=&#8221;1px&#8221;]<\/p>\n<h4 class=\"title\">Volume 20, Issue 1, March 2018<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; specialty=&#8221;on&#8221; _builder_version=&#8221;3.22&#8243; custom_padding=&#8221;24px|0px|25px|0px|false|false&#8221;][et_pb_column type=&#8221;3_4&#8243; specialty_columns=&#8221;3&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_row_inner _builder_version=&#8221;3.25&#8243;][et_pb_column_inner saved_specialty_column_type=&#8221;3_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;Editoral in Hungarian&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/szerklevel_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/szerklevel_honlapra.pdf&#8221; link_option_url_new_window=&#8221;on&#8221;]<\/p>\n<p>A pszichofarmakol\u00f3gia m\u00faltja, jelen \u00e9s j\u00f6v\u0151je<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract&#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;3.21.4&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]<\/p>\n<h4 class=\"art\">A pszichofarmakol\u00f3gia m\u00faltja, jelen \u00e9s j\u00f6v\u0151je<\/h4>\n<div class=\"autors\">\n<p><span>P\u00e9ter L\u00e1szl\u00f3<\/span><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<hr class=\"system-readmore\" \/>\n<div class=\"artbody\">\n<p>A m\u00falt sz\u00e1zad 50-60-as \u00e9veit\u0151l kezdve a pszichi\u00e1triai betegs\u00e9gek etiol\u00f3gi\u00e1j\u00e1nak egyre jobb megismer\u00e9s\u00e9n keresztu\u0308l az el\u00e9rhet\u0151 pszichofarmakonok sz\u00e1ma ugr\u00e1sszer\u0171en megn\u0151tt. A monoamin hipot\u00e9zis bevezet\u00e9s\u00e9t k\u00f6vet\u0151en a dopamin, szerotonin \u00e9s noradrenalin neurotranszmisszi\u00f3t befoly\u00e1sol\u00f3 szerek szinte az eg\u00e9sz vil\u00e1gon el\u00e9rhet\u0151v\u00e9 v\u00e1ltak. A hagyom\u00e1nyos vagy t\u00edpusos gy\u00f3gyszerekre jellemz\u0151 volt a nagy hat\u00e9konys\u00e1g, viszont mivel sz\u00e1mos egy\u00e9b receptor m\u0171k\u00f6d\u00e9s\u00e9t is \u00e9rintett\u00e9k, ez\u00e9rt a mell\u00e9khat\u00e1sprofiljuk nagyon kedvez\u0151tlen volt. Ennek hat\u00e1s\u00e1ra indult meg a pszichofarmakonok fejleszt\u00e9s\u00e9nek 2. nagyobb hull\u00e1ma az 1980-90-es \u00e9vekben. A szelektiv szerotonin reuptake g\u00e1tl\u00f3k (SSRI-k), a kett\u0151s hat\u00e1s\u00fa antidepressz\u00edvumok vagy az at\u00edpusos antipszichotikumok sokkal kevesebb\u00a0<span>mell\u00e9khat\u00e1ssal rendelkeztek, \u00e9s hat\u00e9konys\u00e1guk sem maradt el a kor\u00e1bbi szerek\u00e9t\u0151l. Az ut\u00f3bbi 10-15 \u00e9vben igaz\u00e1n \u00faj hat\u00e1smechanizmus\u00fa szer nem keru\u0308lt piacra, ink\u00e1bb a kor\u00e1bbi hat\u00f3anyagok m\u00f3dos\u00edtott vagy kombin\u00e1lt v\u00e1ltozatait l\u00e1thatjuk. Napjainkban a generikus gy\u00f3gyszerek t\u00e9rh\u00f3d\u00edt\u00e1sa figyelhet\u0151 meg vil\u00e1gszerte, az origin\u00e1lis k\u00e9sz\u00edtm\u00e9nyek d\u00f6nt\u0151en finansz\u00edroz\u00e1si okok miatt kikopnak az el\u00e9rhet\u0151 gy\u00f3gyszerpalett\u00e1b\u00f3l. A j\u00f6v\u0151 kutat\u00f3inak tal\u00e1n el kellene gondolkozniuk azon, hogy a r\u00e9gebbi gy\u00f3gyszerek hat\u00e9konys\u00e1g\u00e1t hogyan lehetne kombin\u00e1lni az \u00fajabb szerek mell\u00e9khat\u00e1sprofilj\u00e1val. Emellett persze l\u00e1thatunk t\u00f6rekv\u00e9seket olyan m\u00e1s betegs\u00e9gekben haszn\u00e1lt gy\u00f3gyszerek pszichi\u00e1triai adapt\u00e1ci\u00f3j\u00e1ra is, melyek nem a monoamin hipot\u00e9zist veszik alapul, hanem pl. a pszichi\u00e1triai betegs\u00e9geket egyfajta gyullad\u00e1sk\u00e9nt aposztrof\u00e1lj\u00e1k. T\u00f6rt\u00e9ntek m\u00e1r vizsg\u00e1latok gyullad\u00e1scs\u00f6kkent\u0151kkel, anticitokin szerekkel, prosztaglandin inhibitorokkal, immunszupressz\u00edv gy\u00f3gyszerekkel is. B\u00e1r az eredm\u00e9nyek biztat\u00f3ak, de haszn\u00e1latuk egyel\u0151re m\u00e9g nem terjedt el a k\u00f6ztudatban.<\/span><\/p>\n<\/div>\n<p>[\/et_pb_toggle][et_pb_blurb title=&#8221;The development of a short version of TEMPS-A in Hungarian non-clinical samples&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/lang_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.5&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/lang_honlapra.pdf&#8221; link_option_url_new_window=&#8221;on&#8221;]<\/p>\n<p><span>Andras Lang, Barbara Papp, Tamas Inancsi, Peter Dome, Xenia Gonda, \u00a0Zoltan Rihmer, and Zsuzsanna Belteczki<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract&#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;4.6.6&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]Background: The Temperament Evaluation of Memphis, Pisa and San Diego Autoquestionnaire<br \/>\n(TEMPS-A) is a widely used measure of affective temperaments. Affective temperaments refer<br \/>\nto people\u2019s prevailing moods and are important precursors of affective disorders. With the<br \/>\ntwo studies presented in this paper, we aimed to develop a short version of the Hungarian<br \/>\nTEMPS-A. Methods: A total number of 1857 university students participated in two studies.<br \/>\nThe original 110-item version and the newly developed short version of TEMPS-A, the anger,<br \/>\ndepression, and anxiety scales of the PROMIS Emotional Distress item bank, the Altman SelfRating Mania Scale, the Satisfaction With Life Scale, and the Well-Being Index were administered to participants. Results: Out of the original 110 items, 40 items of TEMPS-A loaded on<br \/>\nfive factors that represented the five affective temperaments. Factors of the short version<br \/>\nshowed moderate to strong correlations with their original counterparts. All factors had<br \/>\ngood to excellent internal reliability. Factors of the newly developed short version of TEMPSA showed meaningful correlations with measures of emotional distress, mania, and indices<br \/>\nof psychological well-being. Conclusions: The short version of the Hungarian TEMPS-A is a<br \/>\npromising instrument both in clinical fields and for academic research. The newly developed<br \/>\nshort version proved to be a valid and reliable measure of affective temperaments.<br \/>\n(Neuropsychopharmacol Hung 2018; 20(1): 4\u201313)<\/p>\n<p>Keywords: affective temperaments, TEMPS-A, short version, Hungarian[\/et_pb_toggle][et_pb_blurb title=&#8221;Assessing suicide risk using the Brief Suicide Questionnaire \u2013 preliminary results&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/rihmer_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/rihmer_honlapra.pdf&#8221;]<\/p>\n<p><span>Zoltan Rihmer, Peter Dome, Xenia Gonda, Annamaria Rihmer and Zsuzsanna Belteczki<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract&#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;4.6.6&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]The authors tested the clinical applicability of a self-developed, 6-item, clinician-rated<br \/>\nquestionnaire evaluating suicide risk in suicidal and non-suicidal psychiatric inpatients and<br \/>\nhealthy controls. Results have shown that the questionnaires able to detect marked suicide risk<br \/>\nin psychiatric inpatients with a high sensitivity and specificity which indicates its usefulness<br \/>\nand good applicability in clinical practice.<\/p>\n<p>Keywords: suicide, suicide attempt, suicide risk factors, hierarchical classification, sensitivity,<br \/>\nspecificity[\/et_pb_toggle][et_pb_blurb title=&#8221;N-methyl-D-aspartate receptor antibody encephalitis: the Janus-faced disorder&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/sipos_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/sipos_honlapra.pdf&#8221;]<\/p>\n<p>Ildik\u00f3 Sipos<\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract&#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;4.6.6&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]The recognition of the antibody-mediated encephalitis as a separate entity among the immune<br \/>\ndisorders of the central nervous system was one of the greatest breakthroughs of the last two<br \/>\ndecades in neurology. Unlike viral or tumor-related encephalitis, the antibody-mediated form<br \/>\nhas a good response to immunotherapy, which gives a special clinical importance to the discovery. Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is one of the first fully<br \/>\ncharacterized antibody-mediated encephalitises. This article attempts to summarize the clinical<br \/>\nfeatures of this complex neuropsychiatric disorder with the aim to help its early recognition<br \/>\nand to report the clinical course and the outcome of our six seropositive anti-NMDAR cases.<br \/>\nThe disease appears typically in young females and often combined with ovarian teratoma.<br \/>\nHowever, the antibody production could develop without any malignancy. The course of the<br \/>\nillness is usually monophasic, but 10% of the cases are relapsing. The anti-NMDAR encephalitis<br \/>\nis the result of disturbed glutamatergic neurotransmission due to the internalization of the<br \/>\nreceptor-antibody complexes. The disease usually develops after a common viral infection,<br \/>\nbut recent data proved that anti-NMDAR encephalitis could also develop after herpes simplex<br \/>\nvirus-1 encephalitis. The Janus-faced clinical course of the disease is the obstacle of the early<br \/>\nrecognition. Psychiatric symptoms \u2013 like delusion, hallucination and agitation \u2013 dominate in<br \/>\nthe first, cortical phase of the illness, which are indistinguishable from the signs of primary<br \/>\npsychosis. The true nature of the disease only reveals later, with the appearance of the basal<br \/>\nganglia territory and brainstem sings, such as perioral hyperkinesia and bradycardia. Further<br \/>\ndelays the diagnosis that the leading symptoms of the second phase could be interpreted as<br \/>\nthe side effects of the initial treatment. According to expert psychiatrists, the unusual dynamic<br \/>\nof the psychotic symptoms and the lack of response to the neuroleptic drugs could lead toward<br \/>\nthe idea of the anti-NMDAR encephalitis. The final diagnosis depends on the detection of the<br \/>\nanti-NMDAR antibody from the cerebrospinal fluid or the serum, respectively. Haloperidol is<br \/>\nthe most potent drug to treat the psychotic symptoms of the cortical phase; however due<br \/>\nto its antidopaminergic side effect atypical neuroleptics are recommended by the experts.<br \/>\nThe immunological treatment is the administration of intravenous corticosteroid combined<br \/>\nwith plasma exchange or with intravenous IgG infusion. The immunotherapy in most of the<br \/>\ncases is successful, but the recovery is long and it requires strong cooperation between the<br \/>\npsychiatrists, neurologists and intensive care therapists.<\/p>\n<p>Keywords: anti-NMDAR antibody, autoimmune enkefalitisz, psychosis, immunotherapy[\/et_pb_toggle][et_pb_blurb title=&#8221;The practical considerations of antidepressant use during pregnancy and breastfeeding&#8221; url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/dome_honlapra.pdf&#8221; url_new_window=&#8221;on&#8221; image=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/pdf.png&#8221; icon_placement=&#8221;left&#8221; image_max_width=&#8221;105%&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.6.6&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;17px&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;||on||||||&#8221; body_line_height=&#8221;1.3em&#8221; link_option_url=&#8221;https:\/\/mppt.hu\/magazin\/pdf\/xx-evfolyam-1-szam\/dome_honlapra.pdf&#8221;]<\/p>\n<p>P\u00e9ter D\u00f6me and  G\u00e1bor Faludi <\/p>\n<p>[\/et_pb_blurb][et_pb_toggle title=&#8221;Abstract&#8221; closed_toggle_text_color=&#8221;#000000&#8243; closed_toggle_background_color=&#8221;rgba(0,0,0,0)&#8221; icon_color=&#8221;#0c71c3&#8243; _builder_version=&#8221;4.6.6&#8243; title_font=&#8221;|600|||||||&#8221; title_letter_spacing=&#8221;1px&#8221; text_orientation=&#8221;justified&#8221; custom_padding=&#8221;0px||10px&#8221; border_width_all=&#8221;0px&#8221; border_width_bottom=&#8221;1px&#8221;]Main indications of antidepressants (ADs) as major depressive disorder (MDD) and different<br \/>\nkinds of anxiety disorders are quite prevalent during pregnancy and the postpartum period.<br \/>\nDue to the possible hazards of in utero and breast milk exposition of ADs, both psychiatrists<br \/>\nand mothers frequently have concerns about the use of ADs during the periods of pregnancy<br \/>\nand breastfeeding. However, we should also bear in mind that affective disorders left untreated<br \/>\nduring these periods are also associated with health risks for the mother and the baby as well.<br \/>\nAccordingly, the treatment of affective disorders during these periods is essential. For mild<br \/>\ncases of affective disorders the recommended treatment modality is typically psychotherapy<br \/>\nwhile for the severe cases pharmacotherapy (including AD treatment) is recommended.<br \/>\nUnfortunately, due to the lack of well-designed prospective studies, only sparse information<br \/>\nis available on the efficacy and safety of AD treatment in pregnant and breastfeeding women.<br \/>\nIn this review we try to provide some practical advice in terms of the use of ADs during the<br \/>\nperiods in question.<\/p>\n<p>Keywords: antidepressant, affective disorders, pregnancy, breastfeeding[\/et_pb_toggle][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/mppt.hu\/wp-content\/uploads\/2019\/04\/borito_honlapra_kicsi.jpg&#8221; align_tablet=&#8221;center&#8221; align_phone=&#8221;&#8221; align_last_edited=&#8221;on|desktop&#8221; _builder_version=&#8221;3.23&#8243; box_shadow_style=&#8221;preset3&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u2022 A pszichofarmakol\u00f3gia m\u00faltja, jelen \u00e9s j\u00f6v\u0151je &#8211; P\u00e9ter L\u00e1szl\u00f3<br \/>\n\u2022 The development of a short version of TEMPS-A in Hungarian non-clinical samples &#8211;<br \/>\nAndras Lang, Barbara Papp, Tamas Inancsi, Peter Dome, Xenia Gonda,  Zoltan Rihmer, and Zsuzsanna Belteczki<\/p>\n","protected":false},"author":4,"featured_media":48279,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[57],"project_tag":[],"class_list":["post-48521","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-neuropsychopharmacologia-hungarica-2-en"],"_links":{"self":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project\/48521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/comments?post=48521"}],"version-history":[{"count":8,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project\/48521\/revisions"}],"predecessor-version":[{"id":49507,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project\/48521\/revisions\/49507"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/media\/48279"}],"wp:attachment":[{"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/media?parent=48521"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project_category?post=48521"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/mppt.hu\/en\/wp-json\/wp\/v2\/project_tag?post=48521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}